Literature DB >> 8392580

Dopamine and baclofen inhibit the hyperpolarization-activated cation current in rat ventral tegmental neurones.

Z G Jiang1, M Pessia, R A North.   

Abstract

1. Whole-cell patch-clamp recordings were made from dopamine-containing ventral tegmental area neurones in slices of rat midbrain. An inward current (Ih) was activated by hyperpolarization from -60 mV. 2. Dopamine (30 microM) reduced the amplitude of Ih by 10-30% at potentials from -70 to -120 mV. The effect was concentration dependent, mimicked by the D2 agonist quinpirole, and prevented by the D2 antagonist (-)-sulpiride. Baclofen (0.3-3 microM) also inhibited Ih; this action was antagonized by 2-hydroxysaclofen but not by (-)-sulpiride. The decrease in Ih resulted from a reduction in the maximal current with no change in the voltage dependence. 3. The action of dopamine was unaffected by cadmium (200 microM), forskolin (10 microM), the adenylyl cyclase inhibitor 2',3'-dideoxyadenosine (100 microM), or by intracellular solution containing cyclic AMP (2 mM). 4. Ih was progressively reduced during the first 5-10 min of recording with electrodes containing guanosine 5'-O-(3-thiotriphosphate); after this time, dopamine had no further effect. 5. It is concluded that agonists acting at D2 receptors and GABAB receptors reduce Ih in ventral tegmental neurones.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392580      PMCID: PMC1175326          DOI: 10.1113/jphysiol.1993.sp019580

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  38 in total

1.  Properties of the hyperpolarizing-activated current (if) in cells isolated from the rabbit sino-atrial node.

Authors:  D DiFrancesco; A Ferroni; M Mazzanti; C Tromba
Journal:  J Physiol       Date:  1986-08       Impact factor: 5.182

2.  Voltage-clamp analysis of muscarinic excitation in hippocampal neurons.

Authors:  J V Halliwell; P R Adams
Journal:  Brain Res       Date:  1982-10-28       Impact factor: 3.252

3.  Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. Identification and characterization.

Authors:  A A Grace; B S Bunney
Journal:  Neuroscience       Date:  1983-10       Impact factor: 3.590

4.  Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum.

Authors:  J C Stoof; J W Kebabian
Journal:  Nature       Date:  1981-11-26       Impact factor: 49.962

5.  Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas.

Authors:  P De Camilli; D Macconi; A Spada
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

6.  Inhibitory and excitatory effects of dopamine on Aplysia neurones.

Authors:  P Ascher
Journal:  J Physiol       Date:  1972-08       Impact factor: 5.182

7.  Sensitivity of compacta neurones in the rat substantia nigra slice to dopamine agonists.

Authors:  R D Pinnock
Journal:  Eur J Pharmacol       Date:  1983-12-23       Impact factor: 4.432

8.  A voltage-clamp analysis of inward (anomalous) rectification in mouse spinal sensory ganglion neurones.

Authors:  M L Mayer; G L Westbrook
Journal:  J Physiol       Date:  1983-07       Impact factor: 5.182

9.  The control of firing pattern in nigral dopamine neurons: single spike firing.

Authors:  A A Grace; B S Bunney
Journal:  J Neurosci       Date:  1984-11       Impact factor: 6.167

10.  The control of firing pattern in nigral dopamine neurons: burst firing.

Authors:  A A Grace; B S Bunney
Journal:  J Neurosci       Date:  1984-11       Impact factor: 6.167

View more
  20 in total

1.  Kappa-opioid receptor-mediated enhancement of the hyperpolarization-activated current (I(h)) through mobilization of intracellular calcium in rat nucleus raphe magnus.

Authors:  Zhizhong Z Pan
Journal:  J Physiol       Date:  2003-03-21       Impact factor: 5.182

2.  Chemical transmission between dopaminergic neuron pairs.

Authors:  Marie Vandecasteele; Jacques Glowinski; Jean-Michel Deniau; Laurent Venance
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-17       Impact factor: 11.205

3.  alpha2-Noradrenergic receptors activation enhances excitability and synaptic integration in rat prefrontal cortex pyramidal neurons via inhibition of HCN currents.

Authors:  David B Carr; Glenn D Andrews; William B Glen; A Lavin
Journal:  J Physiol       Date:  2007-08-16       Impact factor: 5.182

4.  Opioid inhibition of hippocampal interneurons via modulation of potassium and hyperpolarization-activated cation (Ih) currents.

Authors:  K R Svoboda; C R Lupica
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

5.  Cooperative activation of D1 and D2 dopamine receptors enhances a hyperpolarization-activated inward current in layer I interneurons.

Authors:  JianPing Wu; John J Hablitz
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.167

6.  Dopamine modulates Ih in a motor axon.

Authors:  Aleksander W Ballo; Jennifer C Keene; Patricia J Troy; Marie L Goeritz; Farzan Nadim; Dirk Bucher
Journal:  J Neurosci       Date:  2010-06-23       Impact factor: 6.167

7.  Hyperpolarization-activated cation current (Ih) is an ethanol target in midbrain dopamine neurons of mice.

Authors:  Takashi Okamoto; Mark T Harnett; Hitoshi Morikawa
Journal:  J Neurophysiol       Date:  2005-09-07       Impact factor: 2.714

8.  MPP(+) -dependent inhibition of Ih reduces spontaneous activity and enhances EPSP summation in nigral dopamine neurons.

Authors:  A Masi; R Narducci; E Landucci; F Moroni; G Mannaioni
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

9.  Repeated cocaine exposure increases fast-spiking interneuron excitability in the rat medial prefrontal cortex.

Authors:  Emilie Campanac; Dax A Hoffman
Journal:  J Neurophysiol       Date:  2013-03-13       Impact factor: 2.714

10.  Pacemaker channels in mouse thalamocortical neurones are regulated by distinct pathways of cAMP synthesis.

Authors:  Samuel G A Frère; Anita Lüthi
Journal:  J Physiol       Date:  2004-01-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.